FDA Adverse Event Malfunction Summary report: N

I-STAT CG8+ CARTRIDGE

MDR report key: 16938190 · Received May 16, 2023

Report

Report Number
2245578-2023-00060
Event Type
Malfunction
Date Received
May 16, 2023
Date of Event
May 10, 2023
Report Date
June 8, 2023
Manufacturer
ABBOTT POINT OF CARE
Product Code
CHL
UDI-DI
10054749000163
PMA / PMN Number
K940918
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
RP
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT: # (B)(4). THE INVESTIGATION WAS COMPLETED ON 07-JUN-2023. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS RELEASE CRITERIA. DUE TO THE EXPIRATION OF CG8+ CARTRIDGE LOT W22265 (22-MAY-2023), RETAINED TESTING COULD NOT BE PERFORMED. NO DEFICIENCY HAS BEEN DETERMINED FOR CG8+ CARTRIDGE LOT W22265.

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 0

ON (B)(6) 2023, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT CG8+ CARTRIDGES THAT YIELDED SUSPECTED DISCREPANT SODIUM AND POTASSIUM RESULTS ON A PATIENT. THERE WAS NO PATIENT INFORMATION AT THE TIME OF THIS REPORT. METHOD DATE TESTED TEST RESULTS SAMPLE I-STAT , (B)(6) 2023, 07:56, NA 114MMOL/L A. LAB, (B)(6) 2023, NI NA 139.45MMOL/L NI. I-STAT, (B)(6) 2023, 07:56 K 6.2MMOL/L A. LAB, (B)(6) 2023, NI K 4.35MMOL/L NI. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON LIMITED INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. THE INVESTIGATION IS UNDERWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2183943 I-STAT CG8+ CARTRIDGE CG8+ CARTRIDGE CHL ABBOTT POINT OF CARE NA W22265 10054749000163

Patients

Seq Age Sex Outcome Treatment
1 Unknown